متلازمة وهيم (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "متلازمة وهيم" in Arabic language version.

refsWebsite

Global rank Arabic rank

17nih.gov

4^th place

6^th place

10doi.org

2^nd place

5^th place

3web.archive.org

1^st place

2semanticscholar.org

11^th place

86^th place

2worldcat.org

5^th place

4^th place

1archives-ouvertes.fr

1,031^st place

1,622^nd place

1archive.org

6^th place

3^rd place

1science.org

1,160^th place

6,410^th place

1clinicaltrials.gov

5,225^th place

3,308^th place

archive.org

Wetzler M، Talpaz M، Kleinerman ES، وآخرون (1990). "A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia". Am. J. Med. ج. 89 ع. 5: 663–72. DOI:10.1016/0002-9343(90)90187-i. PMID:2239986.

archives-ouvertes.fr

hal-pasteur.archives-ouvertes.fr

Lagane B، Chow KY، Balabanian K، وآخرون (يوليو 2008). "CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome" (PDF). Blood. ج. 112 ع. 1: 34–44. DOI:10.1182/blood-2007-07-102103. PMID:18436740. S2CID:7067287. مؤرشف من الأصل (PDF) في 2020-05-07.

clinicaltrials.gov

"Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome - Full Text View - ClinicalTrials.gov". clinicaltrials.gov (بالإنجليزية). Archived from the original on 2022-12-01. Retrieved 2017-02-25.

doi.org

Kawai T، Choi U، Cardwell L، وآخرون (يناير 2007). "WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4". Blood. ج. 109 ع. 1: 78–84. DOI:10.1182/blood-2006-05-025296. PMC:1785067. PMID:16946301.
Hernandez PA، Gorlin RJ، Lukens JN، وآخرون (مايو 2003). "Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease". Nat. Genet. ج. 34 ع. 1: 70–4. DOI:10.1038/ng1149. PMID:12692554. S2CID:25010857.
Lagane B، Chow KY، Balabanian K، وآخرون (يوليو 2008). "CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome" (PDF). Blood. ج. 112 ع. 1: 34–44. DOI:10.1182/blood-2007-07-102103. PMID:18436740. S2CID:7067287. مؤرشف من الأصل (PDF) في 2020-05-07.
Balabanian K، Levoye A، Klemm L، وآخرون (مارس 2008). "Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling". J. Clin. Invest. ج. 118 ع. 3: 1074–84. DOI:10.1172/JCI33187. PMC:2242619. PMID:18274673.
Wetzler M، Talpaz M، Kleinerman ES، وآخرون (1990). "A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia". Am. J. Med. ج. 89 ع. 5: 663–72. DOI:10.1016/0002-9343(90)90187-i. PMID:2239986.
McDermott DH، Lopez J، Deng F، وآخرون (2011). "AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome". J. Cell. Mol. Med. ج. 15 ع. 10: 2071–81. DOI:10.1111/j.1582-4934.2010.01210.x. PMC:3071896. PMID:21070597.
McDermott DH، وآخرون (2011). "The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome". Blood. ج. 118 ع. 18: 4957–62. DOI:10.1182/blood-2011-07-368084. PMC:3208300. PMID:21890643.
Dale DC، وآخرون (نوفمبر 2011). "The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome". Blood. ج. 118 ع. 18: 4963–6. DOI:10.1182/blood-2011-06-360586. PMC:3673761. PMID:21835955.
David H. McDermott؛ Ji-Liang Gao؛ Qian Liu؛ Marie Siwicki؛ Craig Martens؛ Paejonette Jacobs؛ Daniel Velez؛ Erin Yim؛ Christine R. Bryke؛ Nancy Hsu؛ Zunyan Dai؛ Martha M. Marquesen؛ Elina Stregevsky؛ Nana Kwatemaa؛ Narda Theobald؛ Debra A. Long Priel؛ Stefania Pittaluga؛ Mark A. Raffeld؛ Katherine R. Calvo؛ Irina Maric؛ Ronan Desmond؛ Kevin L. Holmes؛ Douglas B. Kuhns؛ Karl Balabanian؛ Françoise Bachelerie؛ Stephen F. Porcella؛ Harry L. Malech؛ Philip M. Murphy (5 فبراير 2015). "Chromothriptic Cure of WHIM Syndrome". Cell. ج. 160 ع. 4: 686–699. DOI:10.1016/j.cell.2015.01.014. ISSN:0092-8674. PMC:4329071. PMID:25662009.
McDermott, David H.; Liu, Qian; Velez, Daniel; Lopez, Lizbeeth; Anaya-O’Brien, Sandra; Ulrick, Jean; Kwatemaa, Nana; Starling, Judy; Fleisher, Thomas A. (10 Apr 2014). "A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor". Blood (بالإنجليزية). 123 (15): 2308–2316. DOI:10.1182/blood-2013-09-527226. ISSN:0006-4971. PMC:3983611. PMID:24523241.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kawai T، Choi U، Cardwell L، وآخرون (يناير 2007). "WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4". Blood. ج. 109 ع. 1: 78–84. DOI:10.1182/blood-2006-05-025296. PMC:1785067. PMID:16946301.
Hernandez PA، Gorlin RJ، Lukens JN، وآخرون (مايو 2003). "Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease". Nat. Genet. ج. 34 ع. 1: 70–4. DOI:10.1038/ng1149. PMID:12692554. S2CID:25010857.
Lagane B، Chow KY، Balabanian K، وآخرون (يوليو 2008). "CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome" (PDF). Blood. ج. 112 ع. 1: 34–44. DOI:10.1182/blood-2007-07-102103. PMID:18436740. S2CID:7067287. مؤرشف من الأصل (PDF) في 2020-05-07.
Balabanian K، Levoye A، Klemm L، وآخرون (مارس 2008). "Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling". J. Clin. Invest. ج. 118 ع. 3: 1074–84. DOI:10.1172/JCI33187. PMC:2242619. PMID:18274673.
Wetzler M، Talpaz M، Kleinerman ES، وآخرون (1990). "A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia". Am. J. Med. ج. 89 ع. 5: 663–72. DOI:10.1016/0002-9343(90)90187-i. PMID:2239986.
McDermott DH، Lopez J، Deng F، وآخرون (2011). "AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome". J. Cell. Mol. Med. ج. 15 ع. 10: 2071–81. DOI:10.1111/j.1582-4934.2010.01210.x. PMC:3071896. PMID:21070597.
McDermott DH، وآخرون (2011). "The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome". Blood. ج. 118 ع. 18: 4957–62. DOI:10.1182/blood-2011-07-368084. PMC:3208300. PMID:21890643.
Dale DC، وآخرون (نوفمبر 2011). "The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome". Blood. ج. 118 ع. 18: 4963–6. DOI:10.1182/blood-2011-06-360586. PMC:3673761. PMID:21835955.
David H. McDermott؛ Ji-Liang Gao؛ Qian Liu؛ Marie Siwicki؛ Craig Martens؛ Paejonette Jacobs؛ Daniel Velez؛ Erin Yim؛ Christine R. Bryke؛ Nancy Hsu؛ Zunyan Dai؛ Martha M. Marquesen؛ Elina Stregevsky؛ Nana Kwatemaa؛ Narda Theobald؛ Debra A. Long Priel؛ Stefania Pittaluga؛ Mark A. Raffeld؛ Katherine R. Calvo؛ Irina Maric؛ Ronan Desmond؛ Kevin L. Holmes؛ Douglas B. Kuhns؛ Karl Balabanian؛ Françoise Bachelerie؛ Stephen F. Porcella؛ Harry L. Malech؛ Philip M. Murphy (5 فبراير 2015). "Chromothriptic Cure of WHIM Syndrome". Cell. ج. 160 ع. 4: 686–699. DOI:10.1016/j.cell.2015.01.014. ISSN:0092-8674. PMC:4329071. PMID:25662009.
McDermott, David H.; Liu, Qian; Velez, Daniel; Lopez, Lizbeeth; Anaya-O’Brien, Sandra; Ulrick, Jean; Kwatemaa, Nana; Starling, Judy; Fleisher, Thomas A. (10 Apr 2014). "A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor". Blood (بالإنجليزية). 123 (15): 2308–2316. DOI:10.1182/blood-2013-09-527226. ISSN:0006-4971. PMC:3983611. PMID:24523241.

ncbi.nlm.nih.gov

Kawai T، Choi U، Cardwell L، وآخرون (يناير 2007). "WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4". Blood. ج. 109 ع. 1: 78–84. DOI:10.1182/blood-2006-05-025296. PMC:1785067. PMID:16946301.
Balabanian K، Levoye A، Klemm L، وآخرون (مارس 2008). "Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling". J. Clin. Invest. ج. 118 ع. 3: 1074–84. DOI:10.1172/JCI33187. PMC:2242619. PMID:18274673.
McDermott DH، Lopez J، Deng F، وآخرون (2011). "AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome". J. Cell. Mol. Med. ج. 15 ع. 10: 2071–81. DOI:10.1111/j.1582-4934.2010.01210.x. PMC:3071896. PMID:21070597.
McDermott DH، وآخرون (2011). "The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome". Blood. ج. 118 ع. 18: 4957–62. DOI:10.1182/blood-2011-07-368084. PMC:3208300. PMID:21890643.
Dale DC، وآخرون (نوفمبر 2011). "The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome". Blood. ج. 118 ع. 18: 4963–6. DOI:10.1182/blood-2011-06-360586. PMC:3673761. PMID:21835955.
David H. McDermott؛ Ji-Liang Gao؛ Qian Liu؛ Marie Siwicki؛ Craig Martens؛ Paejonette Jacobs؛ Daniel Velez؛ Erin Yim؛ Christine R. Bryke؛ Nancy Hsu؛ Zunyan Dai؛ Martha M. Marquesen؛ Elina Stregevsky؛ Nana Kwatemaa؛ Narda Theobald؛ Debra A. Long Priel؛ Stefania Pittaluga؛ Mark A. Raffeld؛ Katherine R. Calvo؛ Irina Maric؛ Ronan Desmond؛ Kevin L. Holmes؛ Douglas B. Kuhns؛ Karl Balabanian؛ Françoise Bachelerie؛ Stephen F. Porcella؛ Harry L. Malech؛ Philip M. Murphy (5 فبراير 2015). "Chromothriptic Cure of WHIM Syndrome". Cell. ج. 160 ع. 4: 686–699. DOI:10.1016/j.cell.2015.01.014. ISSN:0092-8674. PMC:4329071. PMID:25662009.
McDermott, David H.; Liu, Qian; Velez, Daniel; Lopez, Lizbeeth; Anaya-O’Brien, Sandra; Ulrick, Jean; Kwatemaa, Nana; Starling, Judy; Fleisher, Thomas A. (10 Apr 2014). "A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor". Blood (بالإنجليزية). 123 (15): 2308–2316. DOI:10.1182/blood-2013-09-527226. ISSN:0006-4971. PMC:3983611. PMID:24523241.

science.org

Kaiser، Jocelyn (5 فبراير 2015). "Shattered chromosome cures woman of immune disease". Science. مؤرشف من الأصل في 2023-05-26.

semanticscholar.org

api.semanticscholar.org

Hernandez PA، Gorlin RJ، Lukens JN، وآخرون (مايو 2003). "Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease". Nat. Genet. ج. 34 ع. 1: 70–4. DOI:10.1038/ng1149. PMID:12692554. S2CID:25010857.
Lagane B، Chow KY، Balabanian K، وآخرون (يوليو 2008). "CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome" (PDF). Blood. ج. 112 ع. 1: 34–44. DOI:10.1182/blood-2007-07-102103. PMID:18436740. S2CID:7067287. مؤرشف من الأصل (PDF) في 2020-05-07.

web.archive.org

Lagane B، Chow KY، Balabanian K، وآخرون (يوليو 2008). "CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome" (PDF). Blood. ج. 112 ع. 1: 34–44. DOI:10.1182/blood-2007-07-102103. PMID:18436740. S2CID:7067287. مؤرشف من الأصل (PDF) في 2020-05-07.
Kaiser، Jocelyn (5 فبراير 2015). "Shattered chromosome cures woman of immune disease". Science. مؤرشف من الأصل في 2023-05-26.
"Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome - Full Text View - ClinicalTrials.gov". clinicaltrials.gov (بالإنجليزية). Archived from the original on 2022-12-01. Retrieved 2017-02-25.

worldcat.org

David H. McDermott؛ Ji-Liang Gao؛ Qian Liu؛ Marie Siwicki؛ Craig Martens؛ Paejonette Jacobs؛ Daniel Velez؛ Erin Yim؛ Christine R. Bryke؛ Nancy Hsu؛ Zunyan Dai؛ Martha M. Marquesen؛ Elina Stregevsky؛ Nana Kwatemaa؛ Narda Theobald؛ Debra A. Long Priel؛ Stefania Pittaluga؛ Mark A. Raffeld؛ Katherine R. Calvo؛ Irina Maric؛ Ronan Desmond؛ Kevin L. Holmes؛ Douglas B. Kuhns؛ Karl Balabanian؛ Françoise Bachelerie؛ Stephen F. Porcella؛ Harry L. Malech؛ Philip M. Murphy (5 فبراير 2015). "Chromothriptic Cure of WHIM Syndrome". Cell. ج. 160 ع. 4: 686–699. DOI:10.1016/j.cell.2015.01.014. ISSN:0092-8674. PMC:4329071. PMID:25662009.
McDermott, David H.; Liu, Qian; Velez, Daniel; Lopez, Lizbeeth; Anaya-O’Brien, Sandra; Ulrick, Jean; Kwatemaa, Nana; Starling, Judy; Fleisher, Thomas A. (10 Apr 2014). "A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor". Blood (بالإنجليزية). 123 (15): 2308–2316. DOI:10.1182/blood-2013-09-527226. ISSN:0006-4971. PMC:3983611. PMID:24523241.